AAAAAA

   
Results: 1-3 |
Results: 3
Effect of raloxifene on breast cancer cell Ki67 and apoptosis: A double-blind, placebo-controlled, randomized clinical trial in postmenopausal patients
Authors: Dowsett, M Bundred, NJ Decensi, A Sainsbury, RC Lu, YL Hills, MJ Cohen, FJ Veronesi, P O'Brien, MER Scott, T Muchmore, DB
Citation: M. Dowsett et al., Effect of raloxifene on breast cancer cell Ki67 and apoptosis: A double-blind, placebo-controlled, randomized clinical trial in postmenopausal patients, CANC EPID B, 10(9), 2001, pp. 961-966
Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial
Authors: Cauley, JA Norton, L Lippman, ME Eckert, S Krueger, KA Purdie, DW Farrerons, J Karasik, A Mellstrom, D Ng, KW Stepan, JJ Powles, TJ Morrow, M Costa, A Silfen, SL Walls, EL Schmitt, H Muchmore, DB Jordan, VC
Citation: Ja. Cauley et al., Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial, BREAST CANC, 65(2), 2001, pp. 125-134
A comparison of the effects of raloxifene and estrogen on bone in postmenopausal women
Authors: Prestwood, KM Gunness, M Muchmore, DB Lu, YL Wong, M Raisz, LG
Citation: Km. Prestwood et al., A comparison of the effects of raloxifene and estrogen on bone in postmenopausal women, J CLIN END, 85(6), 2000, pp. 2197
Risultati: 1-3 |